List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 93 studies with search of: "malignant mesothelioma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
Conditions: Malignant Mesothelioma;   Metastatic Cancer
Interventions: Other: talc;   Procedure: therapeutic thoracoscopic surgery;   Procedure: therapeutic thoracoscopy;   Procedure: therapeutic videothoracoscopy
2 Completed SU5416 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: semaxanib
3 Completed Gefitinib in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: gefitinib
4 Active, not recruiting Capecitabine in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: capecitabine
5 Active, not recruiting Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed
Condition: Malignant Mesothelioma
Intervention: Drug: raltitrexed
6 Recruiting Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: bortezomib;   Drug: cisplatin
7 Recruiting AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
Condition: Malignant Mesothelioma
Interventions: Drug: cediranib maleate;   Other: laboratory biomarker analysis
8 Active, not recruiting Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: dasatinib;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
9 Active, not recruiting Sorafenib in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: sorafenib tosylate
10 Active, not recruiting PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: vatalanib
11 Active, not recruiting Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma
Conditions: Malignant Mesothelioma;   Perioperative/Postoperative Complications
Interventions: Procedure: quality-of-life assessment;   Procedure: standard follow-up care;   Radiation: radiation therapy
12 Active, not recruiting Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: gemcitabine hydrochloride
13 Active, not recruiting Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: mitomycin C;   Drug: vinblastine;   Drug: vinorelbine ditartrate
14 Active, not recruiting Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Biological: bevacizumab;   Drug: cisplatin;   Drug: gemcitabine hydrochloride
15 Active, not recruiting Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: raltitrexed
16 Completed Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot be Removed by Surgery
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin;   Drug: pemetrexed disodium
17 Active, not recruiting Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: porfimer sodium;   Procedure: adjuvant therapy;   Procedure: conventional surgery
18 Completed An Open-Label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention: Drug: ZD1839
19 Completed Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: epirubicin hydrochloride;   Drug: gemcitabine hydrochloride
20 Completed Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: trabectedin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services